Collegium Pharmaceutical Inc — Quarterly Cash Flow (NASDAQ:COLL) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 1.64 B1.66 B1.63 B1.59 B1.61 B1.66 B Total liabilities 1.4 B1.43 B1.4 B1.36 B1.33 B1.36 B Total equity 234.28 M228.84 M234.43 M232.21 M274.81 M301.68 M Total liabilities & shareholders' equities 1.64 B1.66 B1.63 B1.59 B1.61 B1.66 B Total debt —————— Net debt ——————

ニュース

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

【決算速報】コレギウム・ファーマシューティカル、売上高は予想を下回り、利益は予想を下回る結果に

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates

Collegium Pharmaceutical決算発表控え、Jornay PMに注目集まる

Collegium Pharmaceutical earnings ahead: Jornay PM in focus

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?

Collegium Pharmaceutical to Report Q4 Earnings: What's in the Cards?

Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates

Truist Securities raises Collegium Pharmaceutical stock price target to $58

Collegium Pharmaceutical Stock: Buying The Projected Growth For 2026 (NASDAQ:COLL)

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?